Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-19-047610

Director sold 15,000 shares at $14.85 ($222,750)

  • Director acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
DUGAN RICHARD W Director 2019-08-26 Option exercise +15,000 $14.78 $221,700 50,770 D: show line 1 in the form
DUGAN RICHARD W Director 2019-08-26 Sale −15,000 $14.85 $222,750 35,770 D: show line 2 in the form
Open-market sales · 15,000 sh · avg $14.85 · $222,750

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
DUGAN RICHARD W Director 2019-08-26 Option exercise · Nonstatutory Stock Option (Right to Buy) −15,000 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…